Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates
Carolina Berger, … , Carole Elliott, Stanley R. Riddell
Carolina Berger, … , Carole Elliott, Stanley R. Riddell
Published December 3, 2007
Citation Information: J Clin Invest. 2008;118(1):294-305. https://doi.org/10.1172/JCI32103.
View: Text | PDF
Research Article Immunology

Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates

  • Text
  • PDF
Abstract

The adoptive transfer of antigen-specific T cells that have been expanded ex vivo is being actively pursued to treat infections and malignancy in humans. The T cell populations that are available for adoptive immunotherapy include both effector memory and central memory cells, and these differ in phenotype, function, and homing. The efficacy of adoptive immunotherapy requires that transferred T cells persist in vivo, but identifying T cells that can reproducibly survive in vivo after they have been numerically expanded by in vitro culture has proven difficult. Here we show that in macaques, antigen-specific CD8+ T cell clones derived from central memory T cells, but not effector memory T cells, persisted long-term in vivo, reacquired phenotypic and functional properties of memory T cells, and occupied memory T cell niches. These results demonstrate that clonally derived CD8+ T cells isolated from central memory T cells are distinct from those derived from effector memory T cells and retain an intrinsic capacity that enables them to survive after adoptive transfer and revert to the memory cell pool. These results could have significant implications for the selection of T cells to expand or to engineer for adoptive immunotherapy of human infections or malignancy.

Authors

Carolina Berger, Michael C. Jensen, Peter M. Lansdorp, Mike Gough, Carole Elliott, Stanley R. Riddell

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 Total
Citations: 16 19 21 28 29 37 25 29 27 35 27 34 35 37 28 36 30 10 503
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2014 (34)

Title and authors Publication Year
Chimeric Antigen Receptor Therapy for Cancer
DM Barrett, N Singh, DL Porter, SA Grupp, CH June
Annual Review of Medicine 2014
Engineering Human Peripheral Blood Stem Cell Grafts that Are Depleted of Naïve T Cells and Retain Functional Pathogen-Specific Memory T Cells
M Bleakley, S Heimfeld, LA Jones, C Turtle, D Krause, SR Riddell, W Shlomchik
Biology of Blood and Marrow Transplantation 2014
Advances in Experimental Medicine and Biology
C DeRenzo, S Gottschalk
Advances in experimental medicine and biology 2014
Promoting Thiol Expression Increases the Durability of Antitumor T-cell Functions
P Kesarwani, AA Al-Khami, G Scurti, K Thyagarajan, N Kaur, S Husain, Q Fang, OS Naga, P Simms, G Beeson, C Voelkel-Johnson, E Garrett-Mayer, CC Beeson, MI Nishimura, S Mehrotra
Cancer research 2014
Elimination of Progressive Mammary Cancer by Repeated Administrations of Chimeric Antigen Receptor-Modified T Cells
A Globerson-Levin, T Waks, Z Eshhar
Molecular Therapy 2014
Engineered T cells for cancer treatment
U Anurathapan, AM Leen, MK Brenner, JF Vera
Cytotherapy 2014
Manufacture of Gene-Modified Human T-Cells with a Memory Stem/Central Memory Phenotype
R Gomez-Eerland, B Nuijen, B Heemskerk, N Rooij, JH van Berg, JH Beijnen, W Uckert, P Kvistborg, TN Schumacher, JB Haanen, A Jorritsma
Human Gene Therapy Methods 2014
Relation of clinical culture method to T-cell memory status and efficacy in xenograft models of adoptive immunotherapy
DM Barrett, N Singh, X Liu, S Jiang, CH June, SA Grupp, Y Zhao
Cytotherapy 2014
Allogeneic lymphocyte-licensed DCs expand T cells with improved antitumor activity and resistance to oxidative stress and immunosuppressive factors
C Jin, D Yu, V Hillerdal, AC Wallgren, A Karlsson-Parra, M Essand
Molecular Therapy — Methods & Clinical Development 2014
Prostaglandin E2 promotes survival of naive UCB T cells via the Wnt/β-catenin pathway and alters immune reconstitution after UCBT
L Li, HT Kim, A Nellore, N Patsoukis, V Petkova, S McDonough, I Politikos, S Nikiforow, R Soiffer, JH Antin, K Ballen, C Cutler, J Ritz, VA Boussiotis
Blood Cancer Journal 2014
Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches
A Rambaldi, E Biagi, C Bonini, A Biondi, M Introna
Leukemia 2014
Antigen-Specific Culture of Memory-like CD8 T Cells for Adoptive Immunotherapy
AJ Litterman, DM Zellmer, RS LaRue, SC Jameson, DA Largaespada
Cancer immunology research 2014
Immunologic special forces: anti-pathogen cytotoxic T-lymphocyte immunotherapy following hematopoietic stem cell transplantation
M Keller, C Bollard
ImmunoTargets and Therapy 2014
Adoptive Immunotherapy for Hematological Malignancies Using T Cells Gene-Modified to Express Tumor Antigen-Specific Receptors
H Fujiwara
Pharmaceuticals (Basel, Switzerland) 2014
Therapeutic targeting of naturally presented myeloperoxidase-derived HLA peptide ligands in myeloid leukemia cells by TCR-transgenic T cells
R Klar, S Schober, M Rami, S Mall, J Merl, SM Hauck, M Ueffing, A Admon, J Slotta-Huspenina, M Schwaiger, S Stevanović, RA Oostendorp, DH Busch, C Peschel, AM Krackhardt
Leukemia Supplements 2014
Progress and prospects for engineered T cell therapies
W Qasim, AJ Thrasher
British Journal of Haematology 2014
Adoptive Immunotherapy for Cancer or Viruses
MV Maus, JA Fraietta, BL Levine, M Kalos, Y Zhao, CH June
Annual Review of Immunology 2014
Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15
Y Xu, M Zhang, CA Ramos, A Durett, E Liu, O Dakhova, H Liu, CJ Creighton, AP Gee, HE Heslop, CM Rooney, B Savoldo, G Dotti
Blood 2014
Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells
M Wölfl, PD Greenberg
Nature Protocols 2014
Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy
B Thaci, CE Brown, E Binello, K Werbaneth, P Sampath, S Sengupta
Neuro-Oncology 2014
A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells
M Cartellieri, S Koristka, C Arndt, A Feldmann, S Stamova, M Bonin, K Töpfer, T Krüger, M Geib, I Michalk, A Temme, M Bornhäuser, D Lindemann, G Ehninger, MP Bachmann
PloS one 2014
Homeostatic expansion as a barrier to lymphocyte depletion strategies:
NA Zwang, LA Turka
Current Opinion in Organ Transplantation 2014
The role of CD4+ T cells in BKV-specific T cell immunity
BJ Weist, M Schmueck, H Fuehrer, A Sattler, P Reinke, N Babel
Medical Microbiology and Immunology 2014
Anticancer Tc9 cells
Y Lu, Q Wang, Q Yi
OncoImmunology 2014
Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
H Shi, M Sun, L Liu, Z Wang
Molecular Cancer 2014
Chimeric Antigen Receptors With Mutated IgG4 Fc Spacer Avoid Fc Receptor Binding and Improve T Cell Persistence and Antitumor Efficacy
M Jonnalagadda, A Mardiros, R Urak, X Wang, LJ Hoffman, A Bernanke, WC Chang, W Bretzlaff, R Starr, S Priceman, JR Ostberg, SJ Forman, CE Brown
Molecular Therapy 2014
Advances in T-cell therapy for ALL
SA Grupp
Best Practice & Research Clinical Haematology 2014
Adoptive Therapy With Chimeric Antigen Receptor–Modified T Cells of Defined Subset Composition:
SR Riddell, D Sommermeyer, C Berger, LS Liu, A Balakrishnan, A Salter, M Hudecek, DG Maloney, CJ Turtle
The Cancer Journal 2014
CD19-CAR Trials:
CA Ramos, B Savoldo, G Dotti
The Cancer Journal 2014
Metabolic Engineering of Salmonella Vaccine Bacteria To Boost Human V 2V 2 T Cell Immunity
G Workalemahu, H Wang, KJ Puan, MH Nada, T Kuzuyama, BD Jones, C Jin, CT Morita
Journal of immunology (Baltimore, Md. : 1950) 2014
Safety of Targeting ROR1 in Primates with Chimeric Antigen Receptor-Modified T Cells
C Berger, D Sommermeyer, M Hudecek, M Berger, A Balakrishnan, PJ Paszkiewicz, PL Kosasih, C Rader, SR Riddell
Cancer immunology research 2014
The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity
M Hudecek, D Sommermeyer, PL Kosasih, A Silva-Benedict, L Liu, C Rader, MC Jensen, SR Riddell
Cancer immunology research 2014
Chemokines as Novel and Versatile Reagents for Flow Cytometry and Cell Sorting
ML le Brocq, AR Fraser, G Cotton, K Woznica, CV McCulloch, KD Hewit, CS McKimmie, RJ Nibbs, JD Campbell, GJ Graham
Journal of immunology (Baltimore, Md. : 1950) 2014
Nature Biotechnology's academic spinouts of 2013.
Bouchie A, Allison M, Webb S, DeFrancesco L
Nature Biotechnology 2014

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts